148 related articles for article (PubMed ID: 3475036)
1. Penetration of enoxacin into bronchial secretions.
Fong IW; Vandenbroucke A; Simbul M
Antimicrob Agents Chemother; 1987 May; 31(5):748-51. PubMed ID: 3475036
[TBL] [Abstract][Full Text] [Related]
2. Penetration of enoxacin into human bronchial mucosa.
Marlin GE; Braude PD; Whelan AJ; Somogyi AA
Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
[TBL] [Abstract][Full Text] [Related]
3. Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study.
Davies BI; Maesen FP; Teengs JP
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():83-9. PubMed ID: 6594325
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
Dobbs BR; Gazeley LR; Stewart IA; Edwards IR
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():61-6. PubMed ID: 3162903
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():67-77. PubMed ID: 3162904
[TBL] [Abstract][Full Text] [Related]
6. [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
Morel C; Vergnaud M; Malbruny B; Benard Y
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):781-4. PubMed ID: 3309815
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
Infection; 1986; 14 Suppl 3():S203-8. PubMed ID: 3463543
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
Infection; 1985; 13(5):219-24. PubMed ID: 2933340
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of enoxacin.
Wise R; Lockley R; Dent J; Webberly M
Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
[TBL] [Abstract][Full Text] [Related]
10. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
Prigogine T; Glupczynski Y; Carpiaux JP; Blogie M; Yourassowsky E; Schmerber JS
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():131-6. PubMed ID: 3129390
[TBL] [Abstract][Full Text] [Related]
11. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.
Blaser J; Stone BB; Groner MC; Zinner SH
Antimicrob Agents Chemother; 1987 Jul; 31(7):1054-60. PubMed ID: 3116917
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.
Rudrik JT; Cavalieri SJ; Britt EM
Antimicrob Agents Chemother; 1984 Jul; 26(1):97-100. PubMed ID: 6591853
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
Wise R; Lockley R; Webberly M; Adhami ZN
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():75-81. PubMed ID: 6238932
[TBL] [Abstract][Full Text] [Related]
16. Bone penetration of enoxacin in patients with and without osteomyelitis.
Fong IW; Rittenhouse BR; Simbul M; Vandenbroucke AC
Antimicrob Agents Chemother; 1988 Jun; 32(6):834-7. PubMed ID: 3166359
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic activity in sputum.
Levy J
J Pediatr; 1986 May; 108(5 Pt 2):841-6. PubMed ID: 3701536
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of enoxacin in elderly patients.
Wise R; Baker SL; Misra M; Griggs D
J Antimicrob Chemother; 1987 Mar; 19(3):343-50. PubMed ID: 3471751
[TBL] [Abstract][Full Text] [Related]
19. Penetration of aztreonam into human bronchial secretions.
Bechard DL; Hawkins SS; Dhruv R; Friedhoff LT
Antimicrob Agents Chemother; 1985 Feb; 27(2):263-4. PubMed ID: 4039120
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of ceftibuten in bronchial secretions.
Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
